GlassScriptPhysician profile
Anthony J Cioce
NPI 1063466357
$1,681.26
in general payments reported to CMS, 2019-2025
24 companies · $274 in 2025
The $274 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $50.76 · 2021: $165 · 2022: $349 · 2023: $169 · 2024: $345 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $787.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $786.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $363.84 | 2019-2025 | Repatha, Otezla, Repatha |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $278.64 | 2020-2025 | Xifaxan, Trulance |
| Abbvie INC. | $214.94 | 2022-2025 | Vraylar, Qulipta |
| Novo Nordisk INC | $141.31 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Arbor Pharmaceuticals, INC. | $108.24 | 2019-2022 | |
| Lilly USA, LLC | $92.19 | 2019-2025 | Zepbound, Jardiance, Mounjaro |
| Takeda Pharmaceuticals U.S.A., INC. | $67.94 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $55.46 | 2022-2024 | |
| Bausch Health US, LLC | $41.54 | 2020-2022 | |
| Exact Sciences Corporation | $40.63 | 2023-2025 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $39.63 | 2021-2022 | |
| Althera Pharmaceuticals LLC | $30.71 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $27.17 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $26.46 | 2023 | Edarbi |
| Abbott Laboratories | $22.74 | 2025 | Freestyle Libre 3 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $18.84 | 2025 | Voquezna |
| Currax Pharmaceuticals LLC | $17.55 | 2025 | Contrave |
| Janssen Pharmaceuticals, INC | $14.48 | 2019 | |
| Almatica Pharma LLC | $13.94 | 2023 | Loreev Xr, Gralise |
| Aytu Biopharma, INC. | $13.55 | 2020 | |
| Idorsia Pharmaceuticals US INC | $13.34 | 2023 | Quviviq |
| Ironshore Pharmaceuticals INC. | $13.18 | 2019 | |
| Horizon Therapeutics Plc | $12.88 | 2022 | |
| Kaleo, INC. | $12.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cioce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.